POSEIDA THERAPEUTICS INC (PSTX)
US73730P1084 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to PSTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 14.28. This target is 399.3% above the current price.
PSTX was analyzed by 11 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about PSTX.
In the previous month the buy percentage consensus was at a similar level.
PSTX was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-05-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-12-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-10 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-10 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-23 | HC Wainwright & Co. | Maintains | Buy |
| 2023-02-01 | Cantor Fitzgerald | Reiterate | Overweight |
| 2023-01-04 | HC Wainwright & Co. | Initiate | Buy |
| 2022-08-09 | Piper Sandler | Maintains | Overweight |
| 2022-05-13 | Piper Sandler | Maintains | Overweight |
| 2022-01-07 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-05-18 | BTIG | Initiate | Buy |